Genetic/epigenetic alterations underlie aberrant STAT3 signaling in cancer and perturbation of positive or negative regulatory components in the JAK/STAT pathway that can cause a persistent STAT3 activation are often detected in different tumors (reviewed in [41]). The gene discussed is SOAT1; the disease is cancer.